300511 Shanghai Xuerong Bio-Technology
- 3.65
- 0.000.00%
Shanghai Xuerong Bio-Technology News
Xuerong Biology (300511): Product prices are low in the off-season, leading edible fungus leaders ushered in a difficult reversal
Xue Rong Bio (300511) comments: Flammulina velutipes price decline caused short-term performance pressure capacity expansion to ensure medium-and long-term development
Xuerong Biotech (300511): The decline in the price of enoki mushroom drags down the Q4 performance channel layout and capacity expansion ensures the company's medium- to long-term growth
Xuebong Bio (300511): steady growth in performance and steady increase in market share
Xuebong Biology (300511): the leading performance of Edible Fungi maintains the growth and accelerates the expansion of production capacity
Xuerong Biotech (300511): Rapid expansion of leading production capacity of industrial edible fungi helps performance continue to rise
Xuebong Bio (300511): the leading position of further capacity expansion
Xuebong Bio (300511): Channel expansion, superimposed Flammulina velutipes, price improvement, performance improvement and high growth.
Xuerong creature (300511): the performance is good in the off-season.
Xuebong Bio (300511): sustained high growth in performance is worth looking forward to in the future.
Xuerong Bio (300511): rapid growth in performance in the first half of the year, small packaging expansion to improve profitability
雪榕生物(300511)：拓展优化销售渠道 金针菇毛利率增长明显
雪榕生物(300511)：金针菇毛利率大幅提升 销售渠道逐步完善
雪榕生物(300511)：金针菇盈利景气 深耕多品类和2C端效果显现
雪榕生物(300511)：多渠道发展 龙头地位愈发凸显
雪榕生物(300511)：投资植物肉公司未食达 菌菇龙头向下游食品消费品进军！
雪榕生物(300511)：内外共振新增长可期
雪榕生物(300511)：操帆摇杆 乘风破浪
Xuerong Biotech (300511): Expanding categories and expanding channels, leading domestic edible fungi are poised to launch!
雪榕生物(300511)2019年年报点评：景气度上升叠加成本下降 公司业绩大幅提升
Analysis
Price Target
No Data
